1 not yet recruiting, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow IgA Nephropathy (IgAN): new trials by email Literature Review of IgA Nephropathy (IgAN) trials Research Report on IgA Nephropathy (IgAN)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN) atrasentan - IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN) | Phase 4 | Not yet recruiting | University of Illinois at Chicago | 20 | 2026-09-29 | 2026-09-21 |
| Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy NEFECON, Placebo - IgA Nephropathy (IgAN) | Phase 4 | Recruiting | Nanfang Hospital, Southern Medical University | 288 | 2026-06-23 | 2026-09-02 |
Glomerulonephritis, IGA (2) · Fibrosis (1)
Autoimmune Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Atrasentan (1)
Nanfang Hospital, Southern Medical University (1) · University of Illinois at Chicago (1)
China (1) · United States (1)